We understand that the privacy and security of your health information is important to you
Main Research Findings 1) When administered to rats, DSIP was found to recover motor function following experimentally-induced strokes
This medications safety profile has not been studied in patients under the age of 18, pregnant and lactating people, or those with normal BMIs. At the time of publishing, the FDA has only approved three GLP-1 agonists for weight loss: Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)
Our Tirzepatide is a research-grade peptide formulated to support advanced weight management, glucose control, and metabolic optimization
doi: 10.1007/s11011-025-01649-z
By activating amylin receptors within the central nervous system and gastrointestinal tract, Cagrilintide regulates appetite, promotes satiety, and influences energy balance, making it one of the most extensively studied amylin analogs in obesity and metabolic research